Hungary’s Richter says deal to buy Polpharma fails

Pharma

Hungarian drug maker Richter Gedeon said on Tuesday its takeover of Poland’s Polpharma was not completed as scheduled on Monday, because Polpharma owner Genefar did not agree to the terms of the closure of the deal.

Richter made the announcement on the Budapest bourse’s website www.bet.hu, Richter said last week its plan to create central Europe’s biggest drug producer by taking over Polpharma would likely fail because Genefar had asked for additional payments and guarantees following a slide in the value of Richter’s stock which had been used to finance the deal. (Reuters)

MET Group Records 2nd Most Profitable Year in 2023 Energy Trade

MET Group Records 2nd Most Profitable Year in 2023

Gov't Considering Fuel Price Intervention Government

Gov't Considering Fuel Price Intervention

Wienerberger Lays Cornerstone of HUF 12 bln Concrete Tile Pl... Manufacturing

Wienerberger Lays Cornerstone of HUF 12 bln Concrete Tile Pl...

Time Out Market to Open in Budapest Next Year Food

Time Out Market to Open in Budapest Next Year

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.